红色发育刺激剂类型对血液透析患者血红蛋白变异性的影响
1Division of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu 42415, Republic of Korea.
Journal of clinical medicine
|July 29, 2025
概括
短期作用的红质形成刺激剂 (ESAs) 在血液透析患者中导致血红蛋白变异性最低. 这项研究发现血红蛋白变异性与死亡率或心血管事件之间没有显著联系.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 临床结果研究研究
背景情况:
- 血液透析 (HD) 患者经常经历血红蛋白的变化.
- 红色发育刺激剂 (ESAs) 用于管理HD中的贫血,具有不同的药理动力学特征.
- 了解ESA对血红蛋白稳定性的影响对于患者管理至关重要.
研究的目的:
- 为了比较血液透析患者在三个ESA类型中的血红蛋白变异性.
- 调查血红蛋白变异性与临床结果 (如死亡率和心血管事件) 之间的关联.
主要方法:
- 这是一项回顾性队列研究,使用了来自韩国48726名血液透析患者的数据.
- 患者被分为短期作用,中期作用和长期作用的ESA组.
- 使用从六个月的线性回归的剩余标准偏差量化血红蛋白变异性.
主要成果:
- 与中期 (0.68 g/dL) 和长期 (0.64 g/dL) 组相比,短效ESA组 (0.60 g/dL) 的血红蛋白变异性最低.
- 短暂作用的ESA显示出血红蛋白变异性显著降低.
- 在增加的血红蛋白变异性和全因死亡率或心血管事件之间没有发现显著的关联.
结论:
- 短效ESA与血液透析患者血红蛋白变异性最低相关.
- 中间作用的ESA显示出最高的血红蛋白变异性.
- 在韩国的医疗保健环境中,短效ESA可能会在定期监测下促进更稳定的血红蛋白水平.
更多相关视频
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
598
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.6K
相关概念视频
01:24Factors Affecting Erythropoiesis
3.6K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.6K
01:24Hemodialysis II: Procedure and Complications
137
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
137
01:25Hemodialysis III: Nursing Management
189
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
189
01:25Hemodialysis I: Introduction
301
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
301
01:14Erythropoiesis
4.8K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.8K
01:27Disorders of Erythrocytes
1.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K